Kerri Sullivan, PT | |
151 Fairway Drive, Hurley, NY 12443 | |
(845) 340-8503 | |
Not Available |
Full Name | Kerri Sullivan |
---|---|
Gender | Female |
Speciality | Physical Therapist |
Location | 151 Fairway Drive, Hurley, New York |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1639489271 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225100000X | Physical Therapist | 17755-1 (New York) | Primary |
Mailing Address | Practice Location Address |
---|---|
Kerri Sullivan, PT 151 Fairway Drive, Hurley, NY 12443 Ph: (845) 340-8503 | Kerri Sullivan, PT 151 Fairway Drive, Hurley, NY 12443 Ph: (845) 340-8503 |
News Archive
A pilot study conducted in a small private high school confirms what many have been touting for years: the benefits of a delayed school start time. Judy Owens, MD, a sleep expert with Hasbro Children's Hospital, reports that a modest delay in school start time of only 30 minutes was associated with significant improvements in adolescent alertness, mood and health. Her findings are published in the July issue of the Archives of Pediatric and Adolescent Medicine.
The American Society for Therapeutic Radiology and Oncology has published a new patient information brochure Radiation Therapy for Gynecologic Cancers: Facts to Help People Understand Their Treatment Options to help educate patients and their families about the treatments available for gynecologic cancers.
Women who give birth to multiple babies following IVF treatment are at a higher risk of breast cancer than those giving birth to singletons or who remain childless. Dutch investigators from the Omega study group said the explanation may not be the multiple pregnancy per se but a maternal trait related to a higher implantation potential and to breast cancer itself.
Sepracor Inc. today announced that it has received notification from the U.S. Food and Drug Administration (FDA) that the agency now anticipates completing its review of the STEDESAâ„¢ (eslicarbazepine acetate) New Drug Application (NDA) on April 30, 2010, which is a three-month extension to the original Prescription Drug User Fee Act (PDUFA) date of January 30, 2010.
The CPR Improvement Working Group, formed to help improve cardiopulmonary resuscitation (CPR) skill performance, today announced the results of the first-ever, multi-national attitudinal survey concerning the performance of CPR by healthcare professionals, including doctors, nurses and paramedics. Survey results will be presented concurrently with the American Heart Association's annual meeting in Orlando, Florida at a panel discussion of leading resuscitation experts on Monday, November 16.
› Verified 3 days ago